When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SAGE - Where Will GW Pharmaceuticals Be in 5 Years?
Sage Therapeutics Inc.
GW Pharmaceuticals(NASDAQ: GWPH) paved the way for modulating the cannabinoid pathway and turning that field of science into valuable prescription therapeutics. Over the past five years, GW transitioned from a promising idea to a commercial reality with two approved drugs in the U.S. and Europe.
Image source: Getty Images.
Epidiolex, GW's first drug to attain U.S. Food and Drug Administration (FDA) approval, launched into the market in November 2018 as a treatment for two rare forms of childhood-onset epilepsy. It also marked the FDA's first approval of a cannabis-derived drug.